• Rotigotine in Research: Analytical Rigor and Neuroprotective

  2026-07-27

  Explore the multifaceted role of Rotigotine as a dopamine D2/D3 receptor agonist, focusing on analytical quality, neuroprotection, and advanced applications in Parkinson’s disease research. This article uniquely bridges pharmaceutical assay reliability with mechanistic insights for translational neuroscience.

• AG-221 (Enasidenib) in IDH2-Mutant AML: Applied Protocols &

  2026-07-27

  AG-221 (Enasidenib) enables translational researchers to target metabolic dependencies in IDH2-mutant acute myeloid leukemia (AML) with high-precision 2-hydroxyglutarate reduction and robust, reproducible cell differentiation protocols. This article unpacks optimized workflows, troubleshooting guidance, and actionable innovations—bridging recent mechanistic discoveries with laboratory practice.

• ABT-263 (Navitoclax) Workflows for Precision Apoptosis Resea

  2026-07-26

  ABT-263 (Navitoclax) offers unrivaled selectivity for Bcl-2 proteins, enabling high-fidelity modeling of apoptosis and senolytic responses in cancer and aging research. This guide details stepwise experimental workflows, troubleshooting strategies, and actionable insights for leveraging ABT-263 in advanced apoptosis assays and pediatric leukemia models.

• Streptavidin-Cy3: Precision Biotin Detection for Metastasis

  2026-07-25

  Streptavidin-Cy3 conjugate empowers researchers to visualize biotinylated targets with unmatched clarity in advanced cancer metastasis studies. Its robust signal and high-affinity binding streamline workflows for immunofluorescence, in situ hybridization, and flow cytometry, setting a new benchmark for sensitivity and reproducibility.

• D-Lin-MC3-DMA: Scientific Advances in Ionizable Liposome Del

  2026-07-24

  Explore the scientific breakthroughs of D-Lin-MC3-DMA, a leading ionizable cationic liposome for siRNA and mRNA delivery. This article uniquely examines the integration of machine learning insights with molecular mechanisms, providing a practical guide for advanced nucleic acid therapeutics.

• Intravesical p21 mRNA-LNP Therapy: Restoring Tumor Suppressi

  2026-07-24

  The referenced study demonstrates that intravesical delivery of p21 mRNA encapsulated in lipid nanoparticles (LNPs) achieves robust tumor suppressor restoration and suppresses tumor growth in non–muscle-invasive bladder cancer models. This approach leverages localized, non-viral mRNA therapy to address recurrence and resistance associated with current treatments, marking a significant advance in precision oncology.

• Triacetin Digestion Reveals Dual Metabolic and Regulatory Ro

  2026-07-23

  This study offers the first detailed mapping of triacetin digestion and absorption in rats, showing rapid conversion to acetic acid and glycerol in the upper gut. The findings highlight triacetin’s dual function as both an energy substrate and a regulator of hepatic gene expression, with implications for metabolic disease research and dietary interventions.

• GSK343: Precision EZH2 Inhibitor Workflows in Cancer Researc

  2026-07-23

  GSK343, a potent and selective EZH2 inhibitor, empowers researchers to dissect epigenetic mechanisms underlying cancer cell proliferation and gene repression with unmatched specificity. This article delivers actionable workflows, troubleshooting strategies, and translational insights that position GSK343 from APExBIO as an indispensable tool for reproducible, high-impact epigenetic research.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Use Guide

  2026-07-22

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables sensitive, specific detection of goat IgG primary antibodies in fluorescence-based assays such as ICC/IF, IHC, flow cytometry, and ELISA. It is not suitable for non-goat primaries or for non-fluorescent detection formats. Researchers should follow established storage, handling, and workflow protocols to maximize signal and minimize background.

• BMS 599626 dihydrochloride: Reliable EGFR/ErbB2 Inhibition f

  2026-07-22

  This article delivers scenario-driven, evidence-backed guidance on integrating BMS 599626 dihydrochloride (SKU B5792) into cancer and senescence research workflows. It addresses real laboratory challenges in EGFR/ErbB2 inhibition, protocol optimization, and product selection, supporting reproducible, high-sensitivity cell-based assays.

• RAB31 Governs an ESCRT-Independent Exosome Biogenesis Pathwa

  2026-07-21

  This study identifies RAB31 as a key regulator marking and controlling a novel ESCRT-independent pathway for exosome biogenesis. By elucidating RAB31’s dual role in intraluminal vesicle formation and lysosomal avoidance, the paper provides foundational insights for exosome biology and new angles for molecular trafficking research.

• Amitriptyline HCl: Technical Guidance for Neuropharmacology

  2026-07-21

  Amitriptyline HCl (SKU B2231) enables precise neurotransmitter receptor modulation in neuropharmacology, mood disorder, and neurodegenerative disease research. Best used for experiments requiring rapid solution preparation and strict quality control, it is not recommended for protocols needing long-term solution storage or unvalidated assay conditions.

• Exemestane: Molecular Precision for Estrogen Modulation in R

  2026-07-20

  Explore how Exemestane, a selective steroidal aromatase inhibitor, enables high-fidelity estrogen biosynthesis inhibition and advances the mechanistic toolkit for breast cancer research. This in-depth article uniquely deciphers molecular action, assay impact, and protocol optimization.

• Strategic Neddylation Inhibition: MLN4924 in Translational O

  2026-07-20

  This thought-leadership article examines the mechanistic foundation and translational promise of MLN4924, a potent NEDD8-activating enzyme inhibitor, for researchers targeting the neddylation pathway in cancer. Integrating new insights on the UBE2F-SAG axis and mTORC1-driven liver tumorigenesis, it provides evidence-based recommendations, protocol guidance, and a competitive perspective on deploying MLN4924 in advanced cancer biology research.

• High-Throughput BBB Model: Accurate CNS Drug Permeability Pr

  2026-07-19

  This study presents a validated high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells, integrating lysosomal trapping correction for enhanced prediction of CNS drug permeability. The approach enables robust discrimination of passive diffusion and active transport, streamlining early-phase neurological drug screening.

16762 records 1/1118 page Next 12345 下5页 Last page